Home › Atopische dermatitis (eczeem) › Californië › Los Angeles
Atopische dermatitis (eczeem) klinische studies in Los Angeles, CA
11 studies voor Atopische dermatitis (eczeem) zoeken deelnemers op locaties in en rond Los Angeles (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
RekruterenObservatieonderzoek
- Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RekruterenFase 2
- Novartis Investigative Site, Los Angeles
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
RekruterenFase 2
- Metropolis Dermatology - DTLA, Los Angeles
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
RekruterenFase 2
- Investigational Site, Los Angeles
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
RekruterenFase 2
- UCLA Division of Dermatology, Los Angeles
- Dermatology Research Associate, Los Angeles
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RekruterenFase 2
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- University of California Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RekruterenFase 2
- Inmagene Site 23, Los Angeles
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
RekruterenFase 2
- Enveda Investigative Site, Los Angeles
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
RekruterenFase 2
- California Allergy and Asthma Medical Group, Los Angeles
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RekruterenFase 2
- California Allergy and Asthma Medical Group, Los Angeles
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
RekruterenObservatieonderzoek
- Galderma Investigational Site 7099, Los Angeles
Atopische dermatitis (eczeem) studies in andere steden
- New York City, NY13 studies
- Washington, DC11 studies
- San Antonio, TX10 studies
- San Diego, CA10 studies
- Birmingham, AL9 studies
- Miami, FL9 studies
- Dallas, TX8 studies
- Sacramento, CA8 studies
- Huntington Beach, CA8 studies
- Troy, MI8 studies
- Indianapolis, IN7 studies
- Pittsburgh, PA7 studies
Andere studies in Los Angeles
- Niet-kleincellige longkanker87 studies
- Kanker (alle vormen)74 studies
- Borstkanker73 studies
- Prostaatkanker61 studies
- Colorectale kanker59 studies
- Metastatische kanker57 studies
- Eierstokkanker50 studies
- Longkanker45 studies
- Plaveiselcelcarcinoom van hoofd en hals42 studies
- Aldermeesklierkanker35 studies
- Endometriumkanker34 studies
- Melanoom34 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.